Picture of Crescita Therapeutics logo

CTX — Crescita Therapeutics News Story

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesAdventurousMicro CapSuper Stock

Brief: U.S. FDA Approves Removal Of "Not For Home Use" Label Restriction For Pliaglis

Dec 17 (Reuters) - Crescita Therapeutics Inc  CTX.TO :
    * U.S. FDA APPROVES REMOVAL OF "NOT FOR HOME USE" LABEL
RESTRICTION FOR PLIAGLIS®
    * CRESCITA THERAPEUTICS - FDA APPROVED PRIOR APPROVAL
SUPPLEMENT
FOR PLIAGLIS FOLLOWING MANDATED 6-MONTH REVIEW PROCESS, IN LINE
WITH PDUFA DATE

Source text for Eikon:  ID:nCNWc1F4za 
Further company coverage:  CTX.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Crescita Therapeutics

See all news